What I was going to ask is, considering your experiences primarily in the east, and now that you have moved on from Dr Lal and had other experiences, what do you think has helped them succeed in the east? The background to that question is, why do you think other regions are not quite as robust? I'm not saying they're not successful, just not as robust.

It completely depends on the local level management and how they operate in the market. In the eastern and northern regions, Dr Lal PathLabs is playing aggressively. They are reaching every corner and establishing labs wherever necessary. They have a stronger logistics support, which is essential in the diagnostic industry. If you cannot collect samples on time, you cannot maintain the TAT, which is vital for providing better services, whether B2B or B2C. They are strengthening their logistics and field force, meaning their salespeople. They are aggressively opening headquarters and placing labs in remote areas as needed. These actions are making the east and north regions grow robustly.

One of the features I've noticed within Dr Lal PathLabs and other companies is the home collection service. This involves collecting samples from the patient's home and bringing them to the lab for testing. Is this strategy successful in your experience?

The key is not just offering home collection but providing proper services. Educating phlebotomists is crucial because some patients come for specific tests like sugar, HBC, vitamin, or thyroid tests. Phlebotomists need to communicate effectively and educate patients about package deals for more comprehensive testing at a better price. This education helps phlebotomists convince patients and increase basic services. This is the advantage of home collection.